Heteroaryl quinazoline derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8846700
APP PUB NO 20140011801A1
SERIAL NO

14021639

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are compounds of the following formula and their pharmaceutically-acceptable salts, which have an effect of glucokinase activation and are useful in the field of medicines for treatment for diabetes, obesity, etc.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MSD K KCHIYODA-KU TOKYO 102-8667

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Asai, Masanori Tsukuba, JP 15 34
Iino, Tomoharu Koto-ku, JP 13 78
Ohno, Akio Machida, JP 41 662
Otake, Norikazu Tsukuba, JP 34 143
Suga, Takuya Tsukuba, JP 8 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00